Form 4 for PTCT PTC THERAPEUTICS, INC.
Accepted 2025-09-09 00:00:00 ET · period of report 2025-09-08 · accession 0001415889-25-023986 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-09-09 | 2025-09-08 | PTCT | Pauwels Eric | Chief BUSINESS Off | M - OptEx | $22.74 | +39.9K | 78.9K | +102% | +$906.2K |
| DM | 2025-09-09 | 2025-09-08 | PTCT | Pauwels Eric | Chief BUSINESS Off | S - Sale+OE | $56.92 | -39.9K | 72.9K | -35% | -$2.27M |
| DM | 2025-09-09 | 2025-09-08 | PTCT | Pauwels Eric | Chief BUSINESS Off | M - OptEx | $0.00 | -39.9K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-08 | M | A | 16,698 | $30.86 | 89,610 | D | — | — | (F2) Includes 272 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended June 30, 2025. |
| 2 | Common | Common Stock | 2025-09-08 | S | D | 16,698 | $56.94 | 72,912 | D | — | — | (F3) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $56.59 to $57.41 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2025-09-08 | M | A | 1,238 | $11.32 | 74,150 | D | — | — | |
| 4 | Common | Common Stock | 2025-09-08 | S | D | 6,017 | $56.91 | 72,912 | D | — | — | (F4) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $56.50 to $57.42 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 5 | Common | Common Stock | 2025-09-08 | M | A | 8,528 | $18.01 | 81,440 | D | — | — | |
| 6 | Common | Common Stock | 2025-09-08 | S | D | 8,528 | $56.92 | 72,912 | D | — | — | (F5) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $56.50 to $57.38 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 7 | Common | Common Stock | 2025-09-08 | M | A | 3,713 | $30.86 | 76,625 | D | — | — | |
| 8 | Common | Common Stock | 2025-09-08 | S | D | 3,713 | $56.92 | 72,912 | D | — | — | (F6) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $56.60 to $57.45 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 9 | Common | Common Stock | 2025-09-08 | M | A | 2,406 | $11.23 | 75,318 | D | — | — | |
| 10 | Common | Common Stock | 2025-09-08 | S | D | 2,406 | $56.92 | 72,912 | D | — | — | (F7) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $56.57 to $57.45 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 11 | Common | Common Stock | 2025-09-08 | S | D | 1,238 | $56.85 | 72,912 | D | — | — | (F8) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $56.50 to $57.14 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 12 | Common | Common Stock | 2025-09-08 | M | A | 1,250 | $11.32 | 74,162 | D | — | — | |
| 13 | Common | Common Stock | 2025-09-08 | S | D | 1,250 | $56.86 | 72,912 | D | — | — | (F9) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $56.50 to $57.10 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 14 | Common | Common Stock | 2025-09-08 | M | A | 6,017 | $11.23 | 78,929 | D | — | — | |
| 15 | Derivative | Stock Option (Right to Buy) | 2025-09-08 | M | D | 6,017 | $0.00 | 2,406 | D | $11.23 · — to 2027-01-02 | 6,017 Common Stock | (F10) Currently exercisable. |
| 16 | Derivative | Stock Option (Right to Buy) | 2025-09-08 | M | D | 1,238 | $0.00 | 1,250 | D | $11.32 · — to 2026-02-24 | 1,238 Common Stock | (F10) Currently exercisable. |
| 17 | Derivative | Stock Option (Right to Buy) | 2025-09-08 | M | D | 1,250 | $0.00 | 0 | D | $11.32 · — to 2026-02-24 | 1,250 Common Stock | (F10) Currently exercisable. |
| 18 | Derivative | Stock Option (Right to Buy) | 2025-09-08 | M | D | 16,698 | $0.00 | 3,713 | D | $30.86 · — to 2026-01-03 | 16,698 Common Stock | (F10) Currently exercisable. |
| 19 | Derivative | Stock Option (Right to Buy) | 2025-09-08 | M | D | 2,406 | $0.00 | 0 | D | $11.23 · — to 2027-01-02 | 2,406 Common Stock | (F10) Currently exercisable. |
| 20 | Derivative | Stock Option (Right to Buy) | 2025-09-08 | M | D | 3,713 | $0.00 | 0 | D | $30.86 · — to 2026-01-03 | 3,713 Common Stock | (F10) Currently exercisable. |
| 21 | Derivative | Stock Option (Right to Buy) | 2025-09-08 | M | D | 8,528 | $0.00 | 0 | D | $18.01 · — to 2028-01-02 | 8,528 Common Stock | (F10) Currently exercisable. |